Cathay Biotech (China) Price Prediction
| 688065 Stock | 42.02 0.48 1.13% |
Oversold Vs Overbought
48
Oversold | Overbought |
Quarterly Earnings Growth 0.327 | Wall Street Target Price 69.35 | Quarterly Revenue Growth 0.441 |
Using Cathay Biotech hype-based prediction, you can estimate the value of Cathay Biotech from the perspective of Cathay Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cathay Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Cathay because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cathay Biotech after-hype prediction price | CNY 41.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cathay |
Cathay Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Cathay Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cathay Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cathay Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cathay Biotech Estimiated After-Hype Price Volatility
In the context of predicting Cathay Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cathay Biotech's historical news coverage. Cathay Biotech's after-hype downside and upside margins for the prediction period are 37.69 and 46.05, respectively. We have considered Cathay Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cathay Biotech is not too volatile at this time. Analysis and calculation of next after-hype price of Cathay Biotech is based on 3 months time horizon.
Cathay Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cathay Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cathay Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cathay Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.50 | 4.18 | 0.15 | 0.21 | 2 Events / Month | 2 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
42.02 | 41.87 | 0.36 |
|
Cathay Biotech Hype Timeline
Cathay Biotech is presently traded for 42.02on Shanghai Stock Exchange of China. The entity has historical hype elasticity of -0.15, and average elasticity to hype of competition of -0.21. Cathay is estimated to decline in value after the next headline, with the price expected to drop to 41.87. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -0.36%, whereas the daily expected return is presently at 0.5%. The volatility of related hype on Cathay Biotech is about 1019.51%, with the expected price after the next announcement by competition of 41.81. About 61.0% of the company shares are owned by insiders or employees . The book value of Cathay Biotech was presently reported as 19.74. The company last dividend was issued on the 24th of July 2024. Cathay Biotech had 1.4:1 split on the 20th of July 2022. Assuming the 90 days trading horizon the next estimated press release will be in a few days. Check out Cathay Biotech Basic Forecasting Models to cross-verify your projections.Cathay Biotech Related Hype Analysis
Having access to credible news sources related to Cathay Biotech's direct competition is more important than ever and may enhance your ability to predict Cathay Biotech's future price movements. Getting to know how Cathay Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cathay Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 601899 | Zijin Mining Group | (0.16) | 3 per month | 2.00 | 0.04 | 3.35 | (3.21) | 10.10 | |
| 600309 | Wanhua Chemical Group | (2.40) | 3 per month | 2.24 | 0.02 | 3.92 | (3.47) | 16.38 | |
| 600019 | Baoshan Iron Steel | (0.07) | 3 per month | 2.00 | 0.12 | 4.80 | (3.10) | 17.37 | |
| 600547 | Shandong Gold Mining | (0.35) | 4 per month | 0.00 | (0.07) | 2.59 | (2.95) | 12.15 | |
| 600010 | Inner Mongolia BaoTou | (0.03) | 2 per month | 2.40 | 0.16 | 7.46 | (4.00) | 19.48 | |
| 002460 | Jiangxi Ganfeng Lithium | 0.00 | 0 per month | 3.18 | 0.12 | 9.99 | (6.14) | 20.00 | |
| 603260 | Hoshine Silicon Ind | (0.38) | 1 per month | 2.49 | 0.1 | 4.90 | (3.79) | 17.89 | |
| 600160 | Zhejiang Juhua Co | (0.19) | 2 per month | 1.87 | 0.21 | 6.09 | (3.85) | 15.23 | |
| 000807 | Yunnan Aluminium Co | (0.11) | 1 per month | 2.26 | 0.13 | 5.75 | (3.27) | 15.53 |
Cathay Biotech Additional Predictive Modules
Most predictive techniques to examine Cathay price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cathay using various technical indicators. When you analyze Cathay charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cathay Biotech Predictive Indicators
The successful prediction of Cathay Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cathay Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cathay Biotech based on analysis of Cathay Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cathay Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cathay Biotech's related companies.
Story Coverage note for Cathay Biotech
The number of cover stories for Cathay Biotech depends on current market conditions and Cathay Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cathay Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cathay Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Cathay Biotech Short Properties
Cathay Biotech's future price predictability will typically decrease when Cathay Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cathay Biotech often depends not only on the future outlook of the potential Cathay Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cathay Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 583.4 M |
Complementary Tools for Cathay Stock analysis
When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |